Status:
UNKNOWN
Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
This phase II trial is studying cisplatin or nedaplatin combine with IMRT to evaluate which one is better efficacy and security in nasopharyngeal carcinoma.
Eligibility Criteria
Inclusion
- Age≥18,T1-2aN1-3;T2-4NxNPC,VEGFR+,++,KPS\>70,Life expectancy≥6 months, No uncontrolled hypertension,cardiac failure,diabetes,lunacy
Exclusion
- Distant metastasis, recurrent disease
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01265147
Start Date
January 1 2011
End Date
December 1 2017
Last Update
January 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daping Hospital
Chongqing, China